相关实验视频

Updated: May 2, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

系统性红血性狼症状集群分析的预后见解

Erwan Le Tallec¹, Corentin Bourg², Guillaume Bouzillé³

¹Department of Internal Medicine and Clinical Immunology, CHU de Rennes, Rennes, France erwan.le.tallec@chu-rennes.fr.

|April 10, 2025

概括

这项研究在诊断和随访时确定了系统性红斑狼 (SLE) 三个不同的患者子组. 这些集群揭示了不同的疾病轨迹和预后,有助于个性化SLE管理.

科学领域:

类风湿病学类风湿病学
免疫学免疫学免疫学
临床医学临床医学

背景情况:

系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,严重程度和进展各不相同.
由于疾病表型的动态和异质性质,对SLE患者的分类具有挑战性.
了解不同患者亚组对于预测疾病轨迹和结果至关重要.

研究的目的:

在诊断时和随访期间识别和描述SLE患者的临床集群.
定义具有不同疾病轨迹和预后的子组.
调查已识别的星团在时间上的稳定性.

主要方法:

对278名符合2019年EULAR/ACR标准的SLE患者的回顾性分析.
基于诊断和最后一次诊断时的23种临床表现的等级分类.
使用考克斯回归评估自身抗体分布和生存分析.

主要成果:

在诊断时确定了三个稳定的临床集群,并在上次访问时得到确认.
集群1/1':早期关节/粘皮症状,最佳生存率.
集群2/2':严重的表型 (脏干扰,抗DNA/抗Sm阳性),预后较差.
集群3/3':高比例的混合结合组织疾病 (MCTD) 特征,抗U1-RNP阳性.

结论:

独特的SLE表型包括一个MCTD类型的群体,一个严重/不良预后的群体,以及一个下部内脏参与的群体.
已识别的集群显示出随着时间的推移的稳定性,为SLE进展提供了洞察力.
这些发现支持基于不同临床轨迹的量身定制患者管理的潜力.

关键词:

自动抗体是一种自身抗体.结合组织疾病结合组织疾病系统性红斑性狼红斑性狼系统性狼

更多相关视频

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

相关概念视频

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...